ArticleFrontiers in oncology2025
Case Report: The crucial role of contrast-enhanced ultrasound and intraoperative ultrasound in diagnosing pediatric pancreatoblastoma.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatoblastoma (PB) is a rare malignant neoplasm of the pancreas, primarily affecting children. While some reports have described the imaging characteristics of PB, detailed descriptions of its ultrasound (US) and contrast-enhanced ultrasound (CEUS) features in children are limited. We reported two cases of PB admitted to our hospital with detailed ultrasonographic features. The first case involved a 14-year-old girl who presented with intermittent, unexplained epigastric pain. CEUS revealed a hypoechoic mass with heterogeneous hyperenhancement in the pancreatic head. She underwent pancreaticoduodenectomy and remains disease-free to date. The second case was a 4-year-old boy with a palpable, unexplained mass in the right upper abdomen. US identified a well-defined, heterogeneous mass in the epigastric region with internal point-like hyperechoic areas. The intraoperative US showed portal vein cancer thrombus. He underwent tumor resection along with reconstruction of the portal and superior mesenteric veins. He subsequently received chemotherapy and remained disease-free to date.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.